Promotion of physical activity in obese women through walking and bicycling

Bicycling as a complement to walking for promoting physical activity in abdominally obese, middle-aged women: a randomised, controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN04233243

Enrollment

120

Registered

2007-12-21

Start date

2005-02-05

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal obesity Nutritional, Metabolic, Endocrine Abdominal obesity

Interventions

Participants were allocated to the two programmes in equal numbers: Intervention programme: Bicycling and walking + physician visits and group sessions Control programme: Walking + group sessions

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Healthy volunteers 2. Female 3. Abdominal obesity (waist circumference 88-120 cm) 4. Aged 30-60 years 5. No physician identified contraindication for physical activity 6. Working at least three days per week away from home

Exclusion criteria

Exclusion criteria: 1. No motivation to increase physical activity 2. ElectroCardioGram (ECG) abnormalities

Design outcomes

Primary

Measure	Time frame
Physical activity: 1. Bicycling (proportion reaching the treatment success cut-off of 2 km/day) measured with a trip meter for 7 consecutive days at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months. 2. Walking (proportion reaching the treatment success cut-off of 10,000 steps/day) measured with a Yamax SW-200 pedometer for 7 consecutive days at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months. Transportation: 3. Use of cars in the transport to and from work measured with a 7 day diary at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months. 4. Use of public transport for commuting to and from work measured with a 7 day diary at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months. 5. Bicycling for commuting to and from work measured with a 7 day diary at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months. 6. Walking for commuting to and from work measured with a 7 day diary at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months.	—

Measure

Time frame

Physical activity: 1. Bicycling (proportion reaching the treatment success cut-off of 2 km/day) measured with a trip meter for 7 consecutive days at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months. 2. Walking (proportion reaching the treatment success cut-off of 10,000 steps/day) measured with a Yamax SW-200 pedometer for 7 consecutive days at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months. Transportation: 3. Use of cars in the transport to and from work measured with a 7 day diary at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months. 4. Use of public transport for commuting to and from work measured with a 7 day diary at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months. 5. Bicycling for commuting to and from work measured with a 7 day diary at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months. 6. Walking for commuting to and from work measured with a 7 day diary at the following time points: 0, 2, 4, 6, 8, 10, 12, 14, 16 and 18 months.

—

Secondary

Measure	Time frame
1. Body composition: Dual energy X-ray Absorptiometry (DXA) measured at 0, 6 and 18 months 2. Metabolic risk factors for cardiovascular disease (fasting blood samples analysed at 0, 6 and 18 months) 3. Health related quality of life measured by the 36-item Short Form health survey (SF-36) at 0, 6 and 18 months 4. Day-time sleepiness and sleep quality measured by the Epworth Sleepiness Scale at 0, 6, and 18 months 5. Bone density measured by DXA at 0, 6, and 18 months 6. Predictors of increased physical activity measured at 0, 6, and 18 months (by various questionnaires) 7. Impact of physical activity on eating behaviour measured by the Eating Behavior Frequency scale (EBF) at 0, 6, and 18 months 8. Self-esteem measured by the Rosenberg Self-esteem Inventory at 0, 6, and 18 months	—

Measure

Time frame

1. Body composition: Dual energy X-ray Absorptiometry (DXA) measured at 0, 6 and 18 months 2. Metabolic risk factors for cardiovascular disease (fasting blood samples analysed at 0, 6 and 18 months) 3. Health related quality of life measured by the 36-item Short Form health survey (SF-36) at 0, 6 and 18 months 4. Day-time sleepiness and sleep quality measured by the Epworth Sleepiness Scale at 0, 6, and 18 months 5. Bone density measured by DXA at 0, 6, and 18 months 6. Predictors of increased physical activity measured at 0, 6, and 18 months (by various questionnaires) 7. Impact of physical activity on eating behaviour measured by the Eating Behavior Frequency scale (EBF) at 0, 6, and 18 months 8. Self-esteem measured by the Rosenberg Self-esteem Inventory at 0, 6, and 18 months

—

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026